Sumatriptan modifies cortical free radical release during cortical spreading depression: A novel antimigraine action for sumatriptan?

Brain Research

Volumn 870, Issue 1-2, 2000, Pages 44-53

  Read, Simon J ^a   Parsons, Andrew A ^b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b Cardiovascular Pharmacology   (United States)

Author keywords

Cortical spreading depression; Free radical; Migraine; Sumatripan

Indexed keywords

FREE RADICAL; NITRIC OXIDE; SEROTONIN 1B AGONIST; SEROTONIN 1D AGONIST; SUMATRIPTAN; SUPEROXIDE;

ARTERIAL GAS; ARTICLE; BRAIN LEVEL; CAT; CONTROLLED STUDY; DEPOLARIZATION; DRUG EFFECT; ELECTROCHEMISTRY; MALE; MIGRAINE; MODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SPREADING CORTICAL DEPRESSION;

ANIMALS; CATS; CEREBRAL CORTEX; FREE RADICALS; MALE; MEMBRANE POTENTIALS; MIGRAINE DISORDERS; OXYGEN; PARTIAL PRESSURE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN AGONISTS; SPECIFIC PATHOGEN-FREE ORGANISMS; SPREADING CORTICAL DEPRESSION; SUMATRIPTAN; SUPEROXIDES;

EID: 0034617377     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02400-8     Document Type: Article

References (31)

1. Back T., Kohno K., Hossman K.A. Cortical negative DC deflections following middle cerebral artery occlusion and KCl-induced spreading depression: Effect on blood flow, tissue oxygenation, and electroencephalogram. J. Cereb. Blood Flow Metab. 14:1994;12-19.
2. S. Bingham, P.T. Davey, M. Sammons, P. Raval, P. Overend, A.A. Parsons, Inhibition of inflammation-induced thermal hyperalgesia by sumatriptan through activation of 5-HT 1b/1d receptors. Exp. Neurol. 2000 (in press).
3. Ehrentreich-Forster E., Scheller W., McNeil C.J. Biosensor zur in vivo messung von superoxidradikalen. BlOspektrum. 4:1997;34-37.
4. Fabian R.H., DeWitt D.S., Kent T.A. In vivo detection of superoxide anion production by the brain using cytochrome c electrode. J. Cereb. Blood Flow Metab. 15:1995;242-247.
5. Ferrari M.D., Haan J.A.K., Blokland J., Arndt J.W., Minnee A.H., Zwindermann P. CBF during migraine attacks without aura and effect of sumatriptan. Arch. Neurol. 52:1995;135-139.
6. Friberg L., Olesen J., Iversen H.K., Sperling B. Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan. Lancet. 338:1991;13-17.
7. Goadsby P.J., Kaube H., Hoskin K.L. NO couples cerebral blood flow and metabolism. Brain Res. 595:1992;167-170.
8. Ingvardsen B.K., Laursen H., Olsen U.B., Hansen A.J. Possible mechanism of cfos expression in trigeminal nucleus caudalis following cortical spreading depression. Pain. 72:1997;407-415.
9. Iversen H.K., Olesen J. Nitroglycerin-induced headache is not dependent on histamine release:support for a direct nociceptive action of NO. Cephalalgia. 14:1994;437-442.
10. Iversen H.K., Olesen J., Tfelt-Hansen P. Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics. Pain. 38:1989;17-24.
11. M. Jones, I. Lever, S. Bingham, S.J. Read, A.A Parsons, S. McMahon, Nitric oxide sensitises trigeminal neurones to dural or facial stimulation in a rat model of migraine. Pain 2000 (in press).
12. Kaube H., Goadsby P.J. Anti-migraine compounds fail to modulate the propagation of cortical spreading depression in the cat. Eur. J. Neurol. 34:(1):1994;30-35.
13. Lassen L.H., Ashina M., Christiansen I., Ulrich V., Olesen J. NO synthase inhibition in migraine. Lancet. 349:1997;401-402.
14. Manning P., McNeil C.J., Hillhouse E.W. Direct, real time sensing of free radical production by activated human glioblastoma cells. Free Rad. Biol. Med. 24:1998;1304-1309.
15. Meng W., Colonna D.M., Tobin J.R., Busija D.W. Nitric oxide and prostaglandins interact to mediate arteriolar dilation during cortical spreading depression. Am. J. Physiol. 26:1995;H176-181.
16. Moskowitz M.A., Nozaki K., Kraig R.P. Neocortical spreading depression provoles the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms. J. Neurosci. 13:1993;1167-1177.
17. Olesen J., Iversen H.K., Thomsen L.L. NO supersensitivity: a possible molecular mechanism of migraine pain. Neuroreport. 4:1993;1027-1030.
18. Olesen J., Thomsen L.L., Iversen H. NO is a key molecule in migraine and other vascular headaches. TIPS. 15:(5):1994;149-153.
19. Read S.J., Parsons A.A. NO does not mediate cerebral blood flow changes during cortical spreading depression in the anaesthetised rat. Neurosci. Lett. 250:1998;115-118.
20. S.J. Read, A.A. Parsons, Cortical spreading depression and migraine, in: Edvinsson (Ed.) Experimental Headache Models in Animal and Man, Martin Dunitz Publishers, London, 1999.
21. Read S.J., Manning P., McNeil C.J., Hunter A.J., Parsons A.A. Effects of sumatriptan on nitric oxide and superoxide balance during glyceryl trinitrate infusion in the rat. Implications for antimigraine mechanisms. Brain Res. 847:1999;1-8.
22. Read S.J., Smith M.I., Benham C.D., Hunter A.J., Parsons A.A. Furosemide inhibits regenerative cortical spreading depression in anaesthetised cats. Cephalalgia. 17:1997;826-832.
23. Read S.J., Smith M.I., Hunter A.J., Parsons A.A. Enhanced NO release during cortical spreading depression following infusion of glyceryl trinitrate in the anaesthetised cat. Cephalalgia. 17:1997;159-165.
24. Read S.J., I Smith M., Hunter A.J., Parsons A.A. The dynamics of NO release measured directly and in real time following repeated waves of cortical spreading depression in the anaesthetised cat. Neurosci. Lett. 232:1997;127-130.
25. Scott A.K., Grimes S., Ng K., Critchley M., Brekenridge A.M., Thomson C., Pilgrim A.J. Sumatriptan and cerebral perfusion in healthy volunteers. Br. J. Clin. Pharmacol. 33:1992;401-404.
26. Stamler J.S. Redox signaling: nitrosylation and related target interactions of NO. Cell. 78:1994;931-936.
27. Stepien A., Chalimoniuk M. Level of nitric oxide-dependent cGMP in patients with migraine. Cephalalgia. 18:(9):1998;631-634.
28. Tammeveski K., Tenno T.T., Mashrin A.A., Hillhouse E.W., Manning P., McNeil C.J. Superoxide electrode based on covalently immobilised cytochrome c: modelling studies. Free Rad. Biol. Med. 25:(8):1998;973-978.
29. Tolias C.M., McNeil C.J., Kazlauskaite J., Hillhouse E.W. Superoxide generation from constituitive NO synthase in astrocytes in vitro regulates extracellular NO availability. Free Rad. Biol. Med. 26:1999;99-106.
30. Wahl M., Schilling L., Parsons A.A., Kaumann A. Involvement of calcitonin gene-related peptide (CGRP) and NO (NO) in the pial artery dilatation elicited by cortical spreading depression. Brain Res. 637:1994;204-210.
31. T. Wolf, U. Lindauer, H. Obrig, A. Villringer, U. Dirnagl, Extracellular and intracellular oxygen supply during cortical spreading depression in the rat, in: Ince et al. (Eds.), Oxygen Transport to the tissue XVII. Chapter 38. Plenum Press, New York, 1996.